Quercetin mitigates liver injury in a rat model of liver cholestasis

Document Type : Original Article

Authors

Physiology Department, Faculty of Medicine, Ain Shams University

Abstract

Abstract
Background: cholestasis is a prevalent health problem associated with liver oxidative stress, inflammation, and fibrosis. Quercetin has been shown to afford a beneficial effect in a variety of liver diseases.This study was designed to investigate the potential protective effect of quercetin on liver cholestasis and the possible underlying mechanisms in a rat model of bile duct ligation (BDL).
Methods: This study was carried out on adult male rats which were randomly divided into: Sham-operated, BDL and BDL- quercetin treated (BDL- Q) groups. Quercetin was given by gavage in a dose of 50 mg/kg/day.
Results: Bile duct ligation resulted in a significant increase in serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and liver levels of myeloperoxidase (MPO), tumor necrosis factor alpha (TNF-α),and transforming growth factor beta 1(TGF-β1), along with a significant decrease in serum levels of total proteins (TPs) and liver glutathione peroxidase(GPX) in BDL group versus sham-operated controls. Quercetin treatment significantly lowered serum levels of AST, ALT, ALP, and MPO, TNF-α, and TGF-β1 in liver tissues associated with a significant increase in serum TPs and liver GPX in BDL-Q group versus BDL rats. Histological studies revealed enhancement of inflammation and a significant increase in the percentage area of collagen deposition in BDL versus sham-operated group. These changes were attenuated in BDL-Q group compared to BDL rats.
Conclusions:
Quercetin alleviated cholestasis induced liver injury and improved liver function possibly via attenuating liver oxidative stress, inflammation and fibrosis.

Keywords

Main Subjects

Bulletin of Egyptian Society for Physiological Sciences
Volume 40, Issue 1
January 2020
Pages 84-95

Files

Share

How to cite

Statistics